Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AdaptHealth Corp (AHCO) vs Remitly Global Inc (RELY) Price & Performance

AdaptHealth CorpTrade
Remitly Global IncTrade

Price performance (Past 24H)

Key statistics

AdaptHealth Corp vs Remitly Global Inc — how do they compare? AdaptHealth Corp trades at $5.83 (market cap $753.09M), while Remitly Global Inc trades at $24.16 (market cap $4.97B). The key difference: Remitly Global Inc is far larger — about 6.6× AdaptHealth Corp's market cap, and Remitly Global Inc is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.

AHCORELY
Market Cap
$753.09M$4.97B
Sector
HealthTechnology
52-Week High
$13.38$25.93
52-Week Low
$5.22$12.20
Enterprise Value
$2.77B$4.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AdaptHealth Corp

AdaptHealth Corp. (AHCO) trades at $5.74, up 9.96% in the last session, yet remains under pressure with a bearish technical signal and recent earnings misses. The company reported a Q2 2026 net loss of $228 million with a -6.82% margin, while selling its diabetes unit to focus on sleep and respiratory care. Valuation ratios show a low P/S of 0.23 and P/B of 0.55, but negative profitability metrics highlight operational challenges.

The outlook is mixed: analyst consensus is bullish with a $11 price target, but risks include ongoing losses, fraud investigations, and cost overruns in fixed-price contracts. Upside depends on successful business restructuring and margin improvement, while downside risks from legal and execution issues persist.

Remitly Global Inc

RELY trades at $23.87, up 3.15% today, with a bullish technical signal from moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $0.93 actual versus $0.12 expected, and revenue growth of 20% year-over-year. Net income turned positive in 2025 at $67.93 million, reversing prior losses, with a robust ROE of 32.25%. Recent news highlights expansion into new financial services like the Global Card and a UAE license, driving investor optimism.

Outlook is positive with a consensus price target of $31.00, implying 30% upside, supported by 92% analyst buy ratings. Key opportunities include market share gains and new revenue streams, while risks involve execution of growth initiatives and competitive pressures in the remittance sector. The stock's valuation at a P/E of 16.99 appears reasonable given accelerating profitability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AdaptHealth Corp

AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.

Read more on AHCO

About Remitly Global Inc

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Read more on RELY